FDA Adverse Event Malfunction Summary report: N

BD PHOENIX¿ NMIC-311

MDR report key: 24368848 · Received February 17, 2026

Report

Report Number
1119779-2026-00190
Event Type
Malfunction
Date Received
February 17, 2026
Date of Event
January 22, 2026
Report Date
April 23, 2026
Manufacturer
BECTON DICKINSON & CO. (SPARKS)
Product Code
LON
UDI-DI
30382904494521
PMA / PMN Number
SEE H11
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NY, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THERE WERE MULTIPLE 510K NUMBERS REPORTED TO BE INVOLVED. THE INFORMATION FOR THE ADDITIONAL 510K IS AS FOLLOWS: G4. PMA/510(K)#: K020322, K022129, K023444, K023634, K023858, K024153, K031530, K031699, K031912, K032299, K032567, K032655, K033362, K033458, K033560, K041384, K042932, K052269, K060214, K060217, K060257, K060444, K060447, K061327, K061355, K062207, K062944, K063301, K063486, K063573, K063811, AND K06382. H3. A DEVICE EVALUATION IS ANTICIPATED BUT HAS NOT YET BEGUN. UPON COMPLETION OF THE INVESTIGATION, A SUPPLEMENTAL REPORT WILL BE FILED.

Additional Manufacturer Narrative · 0

INVESTIGATION SUMMARY: THIS COMPLAINT IS FOR HIGH MIC RESULTS FOR CARBAPENEMS WITH ENTEROBACTERIACEAE WHEN USING PANEL PHOENIX NMIC-311 (CATALOG NUMBER 449452) BATCH NUMBER 5287264. THE CUSTOMER RETURNED A SUMMARY OF RESULTS AND BINARY FILES FOR THE INVESTIGATION. THE CUSTOMER NOTED HIGH MIC RESULTS FOR IMIPENEM (IPM) AND ERTAPENEM (ETP) WITH ENTEROBACTER CLOACAE, KLEBSIELLA PNEUMONIAE AND ESCHERICHIA COLI WHEN USING THE COMPLAINT BATCH. THE BATCH HISTORY RECORD WAS SATISFACTORY, AND NO QUALITY NOTIFICATIONS WERE GENERATED DURING MANUFACTURING AND INSPECTION. COMPLAINT TRENDING WAS ANALYZED, AND NO CURRENT TRENDS WERE IDENTIFIED ASSOCIATED WITH THIS DEFECT. HISTORICAL TRENDING WAS REVIEWED AND THERE WERE NO TRENDS FOR HIGH MIC RESULTS FOR PANEL SKU 449452. TO INVESTIGATE, RETENTION PANELS FROM THE COMPLAINT BATCH WERE INOCULATED WITH IN HOUSE ISOLATES KLEBSIELLA PNEUMONIAE 11000, ENTEROBACTER CLOACAE COMPLEX 11061 AND ESCHERICHIA COLI 11002 TO OBSERVE FOR IPM AND ETP MIC RESULTS. NEXT, CONTROL PANELS FROM THE SAME MATERIAL BUT DIFFERENT BATCH WERE INOCULATED WITH IN HOUSE ISOLATES KLEBSIELLA PNEUMONIAE 11000, ENTEROBACTER CLOACAE COMPLEX 11061 AND ESCHERICHIA COLI 11002 TO OBSERVE FOR IPM AND ETP MIC RESULTS. THE INVESTIGATION RETURNED ALL PANELS WITH SATISFACTORY SUSCEPTIBLE IPM AND ETP SIR AND MIC RESULTS, THEREFORE THIS COMPLAINT IS NOT CONFIRMED. BD R&D PERFORMED A BIOCHEMICAL ANALYSIS OF THE CUSTOMER PROVIDED BINARY FILES. THERE WERE NO RESULTS IN THE CHEMICAL REACTIONS THAT STOOD OUT TO BE A DEFINITIVE ROOT CAUSE OF THE FALSE RESISTANCE; IN ADDITION, THERE WERE NO SIGNS OF CONTAMINATION. LAST, ISOLATE CHARACTERISTICS OF TRUE RESISTANCE TO CARBAPENEMS WAS ALSO FOUND IN THE CUSTOMER'S BINARIES. BD WILL CONTINUE TO MONITOR FOR TRENDS AND TAKE ACTION AS NECESSARY.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 PATIENT ISOLATES ENTEROBACTER CLOACAE COMPLEX, ESCHERICHIA COLI, AND KLEBSIELLA PNEUMONIAE HAVE HIGH MIC (FALSE RESISTANT) RESULTS FOR THE DRUGS ERTAPENEM, MEROPENEM, AND IMIPENEM. THE USER STATED THERE HAS BEEN AN INCREASE IN CARBAPENEM-RESISTANT ENTEROBACTERALES (CRE) RATES. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 5 OF 6.

Description of Event or Problem · 0

IT WAS REPORTED WHILE USING THE BD PHOENIX¿ NMIC-311 PATIENT ISOLATES ENTEROBACTER CLOACAE COMPLEX, ESCHERICHIA COLI, AND KLEBSIELLA PNEUMONIAE HAVE HIGH MIC (FALSE RESISTANT) RESULTS FOR THE DRUGS ERTAPENEM, MEROPENEM, AND IMIPENEM. THE USER STATED THERE HAS BEEN AN INCREASE IN CARBAPENEM-RESISTANT ENTEROBACTERALES (CRE) RATES. NO HEALTH IMPACT OR CONSEQUENCE REPORTED. THIS IS REPORT 5 OF 6.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
235043 BD PHOENIX¿ NMIC-311 SYSTEM, TEST, AUTOMATED, ANTIMICROBIAL SUSCEPTIBILITY, SHORT INCUBATION LON BECTON DICKINSON & CO. (SPARKS) 5287264 30382904494521

Patients

Seq Age Sex Outcome Treatment
1 NA Unknown